Inhibikase Therapeutics, Inc.

New Filing
CIK: 0001750149·Pharmaceuticals·DELAWARE·Filed: Feb 7, 2023
Total Offering

$4,200,000

Amount Sold

$4,200,000

Investors

1

First Sale

Jan 27, 2023

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Milton H. Werner Ph.D
Related Person
Dennis Berman
Related Person
Roy Freeman M.D.
Related Person
Paul Grint, M.D.
Related Person
Gisele Dion
Related Person
Joseph Frattaroli, C.P.A.
Related Person

Company

Inhibikase Therapeutics, Inc.

3350 Riverwood Parkway SE/Ste #1900

Atlanta, GA, 30339

(678) 392-3419

SEC Filing

0001209191-23-007563

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Inhibikase Therapeutics, Inc. Form D Filing — $4,200,000 | FilingFlow